돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 659755생성일: 2026년 10월 26일

Triethylamine hydrochloride → Irbesartan

https://huagongshe.com/reaction/659755

반응식

참여 물질

역할이름HCID투입량
반응물Triethylamine hydrochlorideHCID 11130—
반응물Sodium HydroxideHCID 14798—
반응물Sodium AzideHCID 33557—
반응물4'-((2-Butyl-4-oxo-1,3-diazaspiro(4.4)non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrileHCID 9843116—
용매WaterHCID 962—
용매DimethylformamideHCID 6228—
생성물IrbesartanHCID 374995%

반응 단계

A mixture of 2-n-butyl-3-[(2′-cyanobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one (10 g), sodium azide (7.7 g) and triethylamine hydrochloride (7.1 g) in N,N-dimethylformamide (30 ml) was refluxed for 14 hours under stirring. The reaction was cooled to room temperature and 20 ml water was added. The reaction mixture was adjusted to pH of about 12 using 10% NaOH solution. The alkaline solution was washed with toluene (15 ml) and the aqueous phase was neutralized to pH of 6.5 using concentrated HCl. The resulting suspension was stirred for 3 hours at room temperature and filtered to obtain irbesartan (3.4 g, 95% purity by HPLC). Recrystallization of the product using ethanol results in 3.05 g of irbesartan with 99.2% purity and content of the impurity 2-n-butyl-3-[(2′-carboxamidobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one: 0.09%.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08080670B2
출처 데이터셋uspto-grants-2011_12
ORD IDord-88d06e44cbbc4a08b80e3b57e331ef71
출처 메모uspto-grants-2011_12